帝人（3401） – (Correction / Correction of Numerical Data) Notice of Partial Correction of“Consolidated Financial Results for the FY2021 (Ended March 31, 2022)”

To whom it may concern June 13, 2022 Company: Teijin Limited Representative: Akimoto Uchikawa, President and CEO Stock code: 3401 (Prime Market, Tokyo Stock Exchange) Contact: Tomoya Yoshitomi, General Manager, Investor Relations Department TEL: +81-3-3506-4395 (Correction / Correction of Numerical Data) Notice of Partial Correction of “Consolidated Financial Results (Japanese Accounting Standards) for the FY2021 (Ended March 31, 2022)” Teijin Limited (hereinafter, the “Company”) hereby announces that there were matters that should have been partially corrected in the “Consolidated Financial Results (Japanese Accounting Standards) for the FY2021 (Ended March 31, 2022)” published on May 1 2, 2022. Please note that the corrected portions are underlined. 1. Reason for the correction The Company has made partial corrections in the content of the “Summary of Consolidated Financial Results (Japanese Accounting Standards) for the FY2021 (Ended March 31, 2022)” since there were some errors identified after its disclosure. 2. Details of corrections (Corrections are underlined.) (Summary Information Page 2) Reference: Individual results of FY2021 (April 1, 2021 through March 31, 2022) (Percentages are year-on-year changes) Net sales Operating income Ordinary income Net income Million yen 139,388 110,027 ％ 26.7 -11.6 Million yen 10,483 (2,203) ％ ― ― Million yen 27,662 16,987 ％ 62.8 -47.4 Million yen 36,138 (14,669) ％ ― ― (Before Correction) (1) Individual financial results FY2021 FY2020 FY2021 FY2020 E.P.S. Yen 188.16 (76.42) Diluted E.P.S. Yen 187.77 ― (Percentages are year-on-year changes) Net sales Operating income Ordinary income Net income Million yen 139,388 110,027 ％ 26.7 -11.6 Million yen 10,483 (2,203) ％ ― ― Million yen 27,662 16,987 ％ 62.8 -47.4 Million yen 36,138 (14,669) ％ ― ― (After Correction) (1) Individual financial results FY2021 FY2020 FY2021 FY2020 (Page 18) Segment Information, etc. (1) Segment Information (Before Correction) E.P.S. Yen 188.16 (76.42) Diluted E.P.S. Yen 180.59 ― 3) Segment income (loss), segment assets and other items for reportable segments FY2020 results (Apr. 2020 – Mar. 2021) Sales 1) External customers 2) Intersegment transactions or transfers Net sales Segment income(loss) Segment asset Other items Depreciation2 Amortization of goodwill Investments in associates accounted for using equity method Increase in tangible and intangible fixed assets 2 (Million yen) Materials Healthcare Subtotal Others1 Total IT Reportable operating segments Fibers & Products Converting 314,913 3,497 318,410 17,503 189,221 6,329 52 148,674 13 148,687 31,510 125,647 12,015 155 58,112 6,416 64,528 10,402 57,750 897 － 296,976 9,785 306,761 953 466,833 26,198 4,382 818,674 19,712 838,386 60,368 839,451 45,439 4,588 17,837 3,242 21,080 (215) 70,676 932 － 1,760 1,663 6,613 15,223 18,660 43,478 13,313 730 61,806 7,957 5,186 4,285 836,512 22,954 859,466 60,153 910,128 46,371 4,588 33,883 69,763 1. “Others,” which includes the regenerative medicine business and the Engineering business, does not qualify as a reportable operating segment. 2. Depreciation and Increase in tangible and intangible fixed assets included long -term prepaid expenses and their amortization. (Notes) (After Correction) 3) Segment income (loss), segment assets and other items for reportable segments FY2020 results (Apr. 2020 – Mar. 2021) (Million yen) Materials Healthcare Subtotal Others1 Total IT Reportable operating segments Fibers & Products Converting 314,913 3,497 318,410 17,503 189,221 6,329 52 148,674 13 148,687 31,510 125,647 12,015 155 58,112 6,416 64,528 10,402 57,750 897 － 296,976 9,785 306,761 953 466,833 26,198 4,382 818,674 19,712 838,386 60,368 839,451 45,439 4,588 17,837 3,242 21,080 (215) 70,676 932 － 1,760 1,663 6,613 15,223 18,660 40,448 13,313 730 58,776 831 5,186 4,285 836,512 22,954 859,466 60,153 910,128 46,371 4,588 33,883 59,607 Sales 1) External customers 2) Intersegment transactions or transfers Net sales Segment income(loss) Segment asset Other items Depreciation2 Amortization of goodwill Investments in associates accounted for using equity method Increase in tangible and intangible fixed assets 2 (Notes) 1. “Others,” which includes the regenerative medicine business and the Engineering business, does not qualify as a reportable operating segment. 2. Depreciation and Increase in tangible and intangible fixed assets included long -term prepaid expenses and their amortization. (Page 19-20) Segment Information, etc. (1) Segment Information (Before Correction) Reportable operating segments Others segment Elimination of intersegment transactions Net sales Reportable operating segments Others segment (Loss) Elimination of intersegment transactions Corporate expenses* Operating income (Notes) office administration. Reportable operating segments Others segment Corporate assets not allocated to segments* Other Total assets (Notes) 4) Reconcilisation of published figures and aggregates of reportable operating segments (Millions of yen) Net sales FY2020 FY2021 (Millions of yen) Operating income FY2020 FY2021 838,386 21,080 (22,954) 836,512 60,368 (215) 414 (5,636) 54,931 926,462 24,855 (25,263) 926,054 52,792 (2,147) (354) (6,082) 44,208 839,451 70,676 196,175 (65,172) 1,041,131 1,055,886 75,834 144,443 (68,580) 1,207,583 Corporate expenses are expenses that cannot be allocated to individual reportable operating segments and are primarily relate d to head (Millions of yen) Assets FY2020 FY2021 Corporate assets are assets that cannot be allocated to individual reportable operating segments and are primarily related to investments of the parent company in “Cash and time deposits” and “Investments in securities” etc. Other items Total for reportable operating segments Others Adjustment Consolidated total FY2020 FY2021 FY2020 FY2021 FY2020 FY2021 FY2020 FY2021 (Millions of yen) Depreciation Amortization of goodwill 45,439 61,808 4,588 3,824 932 － 1,460 814 909 47,252 64,178 4,588 4,638 881 － － － － Investments in associates accounted for using equity method Increase in tangible fixed assets and intangible fixed assets 15,223 16,985 18,660 22,016 33,883 39,001 61,806 198,665 7,957 1,039 712 1,096 70,475 200,801 (After Correction) 4) Reconcilisation of published figures and aggregates of reportable operating segments (Millions of yen) Net sales FY2020 FY2021 (Millions of yen) Operating income FY2020 FY2021 Reportable operating segments Others segment Elimination of intersegment transactions Net sales Reportable operating segments Others segment (Loss) Elimination of intersegment transactions Corporate expenses* Operating income (Notes) office administration. Reportable operating segments Others segment Corporate assets not allocated to segments* Other Total assets (Notes) 838,386 21,080 (22,954) 836,512 60,368 (215) 414 (5,636) 54,931 926,462 24,855 (25,263) 926,054 52,792 (2,147) (354) (6,082) 44,208 839,451 70,676 196,175 (65,172) 1,041,131 1,055,886 75,834 144,443 (68,580) 1,207,583 Corporate expenses are expenses that cannot be allocated to individual reportable operating segments and are primarily relate d to head (Millions of yen) Assets FY2020 FY2021 Corporate assets are assets that cannot be allocated to individual reportable operating segments and are primarily related to investments of the parent company in “Cash and time deposits” and “Investments in securities” etc. Other items Total for reportable operating segments Others Adjustment Consolidated total FY2020 FY2021 FY2020 FY2021 FY2020 FY2021 FY2020 FY2021 (Millions of yen) Depreciation Amortization of goodwill 45,439 61,808 4,588 3,824 932 － 1,460 814 909 47,252 64,178 4,588 4,638 881 － － － － 15,223 16,985 18,660 22,016 33,883 39,001 58,776 198,665 831 1,039 712 1,096 60,319 200,801 Investments in associates accounted for using equity method Increase in tangible fixed assets and intangible fixed assets